AMRN
HealthcareAmarin Corporation plc
$15.54-0.83 (-5.10%)
Prev Close
$16.37
Open
$16.39
High
$16.70
Low
$15.43
Volume
48.3K
Market Cap
$301.6M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Amarin Corporation plc (AMRN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 18 insider sales totaling $847.7K. The most recent insider transaction was by Berg Aaron (President and CEO), who sold $35.4K worth of shares on Jan 31, 2026. Amarin Corporation plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $301.6M.
Buys (12M)
0
$0.00
Sells (12M)
18
$847.7K
Net Activity
Net Seller
$847.7K
Active Insiders
13
last 12 mo
AMRN Price Chart
AMRN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026↗ | Berg Aaron | President and CEO | Sell | 2,298 | $15.42 | $35.4K | 0 |
| Jan 31, 2026↗ | Fishman Peter L. | SVP, CFO | Sell | 1,318 | $15.42 | $20.3K | 0 |
| Jan 31, 2026↗ | Keenan David Paul | EVP, Chief Operating Officer | Sell | 2,183 | $15.42 | $33.7K | 0 |
| Jan 31, 2026↗ | Ketchum Steven B | EVP, Chief Scientific Officer | Sell | 1,235 | $15.42 | $19.0K | 0 |
| Jan 2, 2026↗ | Fishman Peter L. | SVP, CFO | Sell | 1,356 | $13.96 | $18.9K | 0 |
| Jan 2, 2026↗ | Keenan David Paul | EVP, Chief Operating Officer | Sell | 1,926 | $13.96 | $26.9K | 0 |
| Jan 2, 2026↗ | Ketchum Steven B | EVP, Chief Scientific Officer | Sell | 2,041 | $13.96 | $28.5K | 0 |
| Jan 2, 2026↗ | Provoost Jonathan | EVP, Chief Legal Officer | Sell | 1,488 | $13.96 | $20.8K | 0 |
| Aug 1, 2025↗ | Fishman Peter L. | SVP, CFO | Sell | 160 | $14.52 | $2.3K | 0 |
| Jun 26, 2025↗ | Berg Aaron | President and CEO | Sell | 38,363 | $15.90 | $610.0K | 0 |
| Apr 18, 2025↗ | Bonfiglio Patrice Eadon | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Cohen Paul | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | DiPaolo Mark | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Horn Keith | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | O'Connor Oliver | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Odysseas Kostas D | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Sterling Louis III | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Sullivan Diane E. | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Mar 1, 2025↗ | Fishman Peter L. | SVP, CFO | Sell | 1,748 | $0.64 | $1.1K | 0 |
| Jan 31, 2025↗ | Fishman Peter L. | SVP, CFO | Sell | 31,112 | $0.62 | $19.3K | 0 |
| Jan 30, 2025↗ | Berg Aaron | President and CEO | Sell | 93,505 | $0.62 | $58.0K | 0 |
| Jan 30, 2025↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 93,505 | $0.62 | $58.0K | 0 |
| Aug 2, 2024↗ | Berg Aaron | President and CEO | Buy | 160,000 | $0.64 | $102.4K | 0 |
| Jul 31, 2024↗ | Berg Aaron | President and CEO | Sell | 11,763 | $0.78 | $9.2K | 0 |
| Jul 1, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 8,209 | $0.69 | $5.7K | 0 |
| Jun 20, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 16,417 | $0.73 | $12.0K | 0 |
| Jan 31, 2024↗ | Berg Aaron | EVP, President US | Sell | 40,822 | $1.24 | $50.6K | 0 |
| Jan 31, 2024↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 41,187 | $1.24 | $51.1K | 0 |
| Jan 31, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 24,552 | $1.24 | $30.4K | 0 |
| Jan 22, 2024↗ | Holt Patrick | President and CEO | Buy | 14,426 | $1.09 | $15.7K | 0 |
| Jan 10, 2024↗ | Berg Aaron | EVP, President US | Sell | 28,214 | $0.97 | $27.4K | 0 |
| Jan 10, 2024↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 28,270 | $0.97 | $27.4K | 0 |
| Jan 10, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 28,325 | $0.97 | $27.5K | 0 |
| Jan 4, 2024↗ | Berg Aaron | EVP, President US | Sell | 15,460 | $0.87 | $13.5K | 0 |
| Jan 4, 2024↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 7,730 | $0.87 | $6.7K | 0 |
| Dec 29, 2023↗ | Berg Aaron | EVP, President US | Sell | 23,525 | $0.87 | $20.5K | 0 |
| Dec 29, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 23,525 | $0.87 | $20.5K | 0 |
| Dec 12, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 34,131 | $0.79 | $27.0K | 0 |
| Aug 16, 2023↗ | Holt Patrick | President and CEO | Buy | 300,000 | $1.04 | $312.3K | 0 |
| Jul 31, 2023↗ | Berg Aaron | EVP, President US | Sell | 11,763 | $1.19 | $14.0K | 0 |
| Jul 31, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 23,526 | $0.98 | $23.2K | 0 |
| Jun 20, 2023↗ | Reilly Thomas Charles | SVP and CFO | Sell | 24,626 | $1.19 | $29.3K | 0 |
| Feb 28, 2023↗ | Berg Aaron | EVP, President US | Sell | 7,718 | $2.03 | $15.7K | 0 |
| Feb 28, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 7,718 | $2.03 | $15.7K | 0 |
| Jan 31, 2023↗ | Berg Aaron | EVP, President US | Sell | 41,869 | $1.82 | $76.2K | 0 |
| Jan 31, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 28,226 | $1.83 | $51.6K | 0 |
| Jan 31, 2023↗ | Mikhail Karim | President and CEO | Sell | 72,311 | $1.85 | $133.9K | 0 |
| Dec 30, 2022↗ | Berg Aaron | EVP, President US | Sell | 16,361 | $1.21 | $19.8K | 0 |
| Dec 30, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 16,361 | $1.21 | $19.8K | 0 |
| Dec 30, 2022↗ | Mikhail Karim | President and CEO | Sell | 1,270 | $1.21 | $1.5K | 0 |
| Aug 19, 2022↗ | Marks Jason M. | EVP,Chief Global Legal Officer | Sell | 11,417 | $1.60 | $18.3K | 0 |
| Jul 29, 2022↗ | Berg Aaron | EVP, President US | Sell | 8,181 | $1.33 | $10.9K | 0 |
| Jul 29, 2022↗ | Kalb Michael Wayne | SVP and CFO | Sell | 46,902 | $1.33 | $62.4K | 0 |
| Jul 29, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 8,181 | $1.33 | $10.9K | 0 |
| Jul 1, 2022↗ | Mikhail Karim | President and CEO | Sell | 10,780 | $1.49 | $16.1K | 0 |
| Jun 13, 2022↗ | WOLD OLSEN PER | Director | Buy | 55,000 | $1.69 | $92.7K | 0 |
| Apr 12, 2022↗ | Mikhail Karim | President and CEO | Sell | 20,631 | $3.35 | $69.1K | 0 |
| Feb 28, 2022↗ | Kalb Michael Wayne | SVP and CFO | Sell | 6,213 | $3.27 | $20.3K | 0 |
| Feb 28, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 5,508 | $3.27 | $18.0K | 0 |
| Jan 31, 2022↗ | Kalb Michael Wayne | SVP and CFO | Sell | 5,317 | $3.36 | $17.9K | 0 |
| Jan 31, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 5,121 | $3.36 | $17.2K | 0 |
| Dec 31, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 25,379 | $3.35 | $85.0K | 0 |
| Dec 31, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 24,433 | $3.35 | $81.9K | 0 |
| Dec 31, 2021↗ | Mikhail Karim | President and CEO | Sell | 3,876 | $3.35 | $13.0K | 0 |
| Dec 14, 2021↗ | Zakrzewski Joseph S | Director | Buy | 12,000 | $3.25 | $39.0K | 0 |
| Aug 31, 2021↗ | Berg Aaron | EVP, President US | Sell | 3,011 | $5.54 | $16.7K | 0 |
| Aug 31, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 3,011 | $5.54 | $16.7K | 0 |
| Aug 31, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,127 | $5.54 | $17.3K | 0 |
| Aug 12, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 120,000 | $5.25 | $630.2K | 0 |
| Jul 30, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,011 | $4.14 | $12.5K | 0 |
| Jul 30, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 3,011 | $4.14 | $12.5K | 0 |
| Jul 30, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $4.14 | $15.7K | 0 |
| Jul 30, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,127 | $4.14 | $12.9K | 0 |
| Jul 30, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $4.14 | $43.9K | 0 |
| Jun 30, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,011 | $4.48 | $13.5K | 0 |
| Jun 30, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 3,011 | $4.48 | $13.5K | 0 |
| Jun 30, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $4.48 | $17.0K | 0 |
| Jun 30, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,127 | $4.48 | $14.0K | 0 |
| Jun 30, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $4.48 | $47.5K | 0 |
| Jun 3, 2021↗ | STACK DAVID M | Director | Buy | 15,000 | $4.56 | $68.5K | 0 |
| May 28, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,012 | $4.54 | $13.7K | 0 |
| May 28, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 2,995 | $4.54 | $13.6K | 0 |
| May 28, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $4.54 | $17.3K | 0 |
| May 28, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,128 | $4.54 | $14.2K | 0 |
| May 28, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $4.54 | $48.1K | 0 |
| Apr 30, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 15,817 | $5.12 | $81.0K | 0 |
| Apr 30, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 2,995 | $5.24 | $15.7K | 0 |
| Apr 30, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $5.24 | $19.9K | 0 |
| Apr 30, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,128 | $5.24 | $16.4K | 0 |
| Apr 30, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $5.24 | $55.6K | 0 |
| Mar 31, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,012 | $6.37 | $19.2K | 0 |
| Mar 31, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 2,995 | $6.37 | $19.1K | 0 |
| Mar 31, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $6.37 | $24.2K | 0 |
| Mar 31, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,128 | $6.37 | $19.9K | 0 |
| Mar 31, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $6.37 | $67.5K | 0 |
| Feb 25, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 54,695 | $7.19 | $393.1K | 0 |
| Feb 25, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 54,450 | $7.19 | $391.3K | 0 |
| Feb 25, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 67,544 | $7.20 | $486.1K | 0 |
| Feb 25, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 56,810 | $7.19 | $408.3K | 0 |
| Feb 25, 2021↗ | THERO JOHN F | President and CEO | Sell | 187,704 | $7.20 | $1.35M | 0 |
AMRN Insider Buying Activity
The following table shows recent insider purchases of Amarin Corporation plc (AMRN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 2, 2024↗ | Berg Aaron | President and CEO | Buy | 160,000 | $0.64 | $102.4K | 0 |
| Jan 22, 2024↗ | Holt Patrick | President and CEO | Buy | 14,426 | $1.09 | $15.7K | 0 |
| Aug 16, 2023↗ | Holt Patrick | President and CEO | Buy | 300,000 | $1.04 | $312.3K | 0 |
| Jun 13, 2022↗ | WOLD OLSEN PER | Director | Buy | 55,000 | $1.69 | $92.7K | 0 |
| Dec 14, 2021↗ | Zakrzewski Joseph S | Director | Buy | 12,000 | $3.25 | $39.0K | 0 |
| Jun 3, 2021↗ | STACK DAVID M | Director | Buy | 15,000 | $4.56 | $68.5K | 0 |
AMRN Insider Selling Activity
The following table shows recent insider sales of Amarin Corporation plc (AMRN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 31, 2026↗ | Berg Aaron | President and CEO | Sell | 2,298 | $15.42 | $35.4K | 0 |
| Jan 31, 2026↗ | Fishman Peter L. | SVP, CFO | Sell | 1,318 | $15.42 | $20.3K | 0 |
| Jan 31, 2026↗ | Keenan David Paul | EVP, Chief Operating Officer | Sell | 2,183 | $15.42 | $33.7K | 0 |
| Jan 31, 2026↗ | Ketchum Steven B | EVP, Chief Scientific Officer | Sell | 1,235 | $15.42 | $19.0K | 0 |
| Jan 2, 2026↗ | Fishman Peter L. | SVP, CFO | Sell | 1,356 | $13.96 | $18.9K | 0 |
| Jan 2, 2026↗ | Keenan David Paul | EVP, Chief Operating Officer | Sell | 1,926 | $13.96 | $26.9K | 0 |
| Jan 2, 2026↗ | Ketchum Steven B | EVP, Chief Scientific Officer | Sell | 2,041 | $13.96 | $28.5K | 0 |
| Jan 2, 2026↗ | Provoost Jonathan | EVP, Chief Legal Officer | Sell | 1,488 | $13.96 | $20.8K | 0 |
| Aug 1, 2025↗ | Fishman Peter L. | SVP, CFO | Sell | 160 | $14.52 | $2.3K | 0 |
| Jun 26, 2025↗ | Berg Aaron | President and CEO | Sell | 38,363 | $15.90 | $610.0K | 0 |
| Apr 18, 2025↗ | Bonfiglio Patrice Eadon | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Cohen Paul | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | DiPaolo Mark | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Horn Keith | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | O'Connor Oliver | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Odysseas Kostas D | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Sterling Louis III | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Apr 18, 2025↗ | Sullivan Diane E. | Director | Sell | 437 | $9.11 | $4.0K | 0 |
| Mar 1, 2025↗ | Fishman Peter L. | SVP, CFO | Sell | 1,748 | $0.64 | $1.1K | 0 |
| Jan 31, 2025↗ | Fishman Peter L. | SVP, CFO | Sell | 31,112 | $0.62 | $19.3K | 0 |
| Jan 30, 2025↗ | Berg Aaron | President and CEO | Sell | 93,505 | $0.62 | $58.0K | 0 |
| Jan 30, 2025↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 93,505 | $0.62 | $58.0K | 0 |
| Jul 31, 2024↗ | Berg Aaron | President and CEO | Sell | 11,763 | $0.78 | $9.2K | 0 |
| Jul 1, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 8,209 | $0.69 | $5.7K | 0 |
| Jun 20, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 16,417 | $0.73 | $12.0K | 0 |
| Jan 31, 2024↗ | Berg Aaron | EVP, President US | Sell | 40,822 | $1.24 | $50.6K | 0 |
| Jan 31, 2024↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 41,187 | $1.24 | $51.1K | 0 |
| Jan 31, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 24,552 | $1.24 | $30.4K | 0 |
| Jan 10, 2024↗ | Berg Aaron | EVP, President US | Sell | 28,214 | $0.97 | $27.4K | 0 |
| Jan 10, 2024↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 28,270 | $0.97 | $27.4K | 0 |
| Jan 10, 2024↗ | Reilly Thomas Charles | EVP and CFO | Sell | 28,325 | $0.97 | $27.5K | 0 |
| Jan 4, 2024↗ | Berg Aaron | EVP, President US | Sell | 15,460 | $0.87 | $13.5K | 0 |
| Jan 4, 2024↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 7,730 | $0.87 | $6.7K | 0 |
| Dec 29, 2023↗ | Berg Aaron | EVP, President US | Sell | 23,525 | $0.87 | $20.5K | 0 |
| Dec 29, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 23,525 | $0.87 | $20.5K | 0 |
| Dec 12, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 34,131 | $0.79 | $27.0K | 0 |
| Jul 31, 2023↗ | Berg Aaron | EVP, President US | Sell | 11,763 | $1.19 | $14.0K | 0 |
| Jul 31, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 23,526 | $0.98 | $23.2K | 0 |
| Jun 20, 2023↗ | Reilly Thomas Charles | SVP and CFO | Sell | 24,626 | $1.19 | $29.3K | 0 |
| Feb 28, 2023↗ | Berg Aaron | EVP, President US | Sell | 7,718 | $2.03 | $15.7K | 0 |
| Feb 28, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 7,718 | $2.03 | $15.7K | 0 |
| Jan 31, 2023↗ | Berg Aaron | EVP, President US | Sell | 41,869 | $1.82 | $76.2K | 0 |
| Jan 31, 2023↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 28,226 | $1.83 | $51.6K | 0 |
| Jan 31, 2023↗ | Mikhail Karim | President and CEO | Sell | 72,311 | $1.85 | $133.9K | 0 |
| Dec 30, 2022↗ | Berg Aaron | EVP, President US | Sell | 16,361 | $1.21 | $19.8K | 0 |
| Dec 30, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 16,361 | $1.21 | $19.8K | 0 |
| Dec 30, 2022↗ | Mikhail Karim | President and CEO | Sell | 1,270 | $1.21 | $1.5K | 0 |
| Aug 19, 2022↗ | Marks Jason M. | EVP,Chief Global Legal Officer | Sell | 11,417 | $1.60 | $18.3K | 0 |
| Jul 29, 2022↗ | Berg Aaron | EVP, President US | Sell | 8,181 | $1.33 | $10.9K | 0 |
| Jul 29, 2022↗ | Kalb Michael Wayne | SVP and CFO | Sell | 46,902 | $1.33 | $62.4K | 0 |
| Jul 29, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 8,181 | $1.33 | $10.9K | 0 |
| Jul 1, 2022↗ | Mikhail Karim | President and CEO | Sell | 10,780 | $1.49 | $16.1K | 0 |
| Apr 12, 2022↗ | Mikhail Karim | President and CEO | Sell | 20,631 | $3.35 | $69.1K | 0 |
| Feb 28, 2022↗ | Kalb Michael Wayne | SVP and CFO | Sell | 6,213 | $3.27 | $20.3K | 0 |
| Feb 28, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 5,508 | $3.27 | $18.0K | 0 |
| Jan 31, 2022↗ | Kalb Michael Wayne | SVP and CFO | Sell | 5,317 | $3.36 | $17.9K | 0 |
| Jan 31, 2022↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 5,121 | $3.36 | $17.2K | 0 |
| Dec 31, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 25,379 | $3.35 | $85.0K | 0 |
| Dec 31, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 24,433 | $3.35 | $81.9K | 0 |
| Dec 31, 2021↗ | Mikhail Karim | President and CEO | Sell | 3,876 | $3.35 | $13.0K | 0 |
| Aug 31, 2021↗ | Berg Aaron | EVP, President US | Sell | 3,011 | $5.54 | $16.7K | 0 |
| Aug 31, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 3,011 | $5.54 | $16.7K | 0 |
| Aug 31, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,127 | $5.54 | $17.3K | 0 |
| Aug 12, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 120,000 | $5.25 | $630.2K | 0 |
| Jul 30, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,011 | $4.14 | $12.5K | 0 |
| Jul 30, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 3,011 | $4.14 | $12.5K | 0 |
| Jul 30, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $4.14 | $15.7K | 0 |
| Jul 30, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,127 | $4.14 | $12.9K | 0 |
| Jul 30, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $4.14 | $43.9K | 0 |
| Jun 30, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,011 | $4.48 | $13.5K | 0 |
| Jun 30, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 3,011 | $4.48 | $13.5K | 0 |
| Jun 30, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $4.48 | $17.0K | 0 |
| Jun 30, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,127 | $4.48 | $14.0K | 0 |
| Jun 30, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $4.48 | $47.5K | 0 |
| May 28, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,012 | $4.54 | $13.7K | 0 |
| May 28, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 2,995 | $4.54 | $13.6K | 0 |
| May 28, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $4.54 | $17.3K | 0 |
| May 28, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,128 | $4.54 | $14.2K | 0 |
| May 28, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $4.54 | $48.1K | 0 |
| Apr 30, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 15,817 | $5.12 | $81.0K | 0 |
| Apr 30, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 2,995 | $5.24 | $15.7K | 0 |
| Apr 30, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $5.24 | $19.9K | 0 |
| Apr 30, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,128 | $5.24 | $16.4K | 0 |
| Apr 30, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $5.24 | $55.6K | 0 |
| Mar 31, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 3,012 | $6.37 | $19.2K | 0 |
| Mar 31, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 2,995 | $6.37 | $19.1K | 0 |
| Mar 31, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 3,803 | $6.37 | $24.2K | 0 |
| Mar 31, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 3,128 | $6.37 | $19.9K | 0 |
| Mar 31, 2021↗ | THERO JOHN F | President and CEO | Sell | 10,604 | $6.37 | $67.5K | 0 |
| Feb 25, 2021↗ | Berg Aaron | CHIEF COMMERCIAL OFFICER | Sell | 54,695 | $7.19 | $393.1K | 0 |
| Feb 25, 2021↗ | Kalb Michael Wayne | SVP and CFO | Sell | 54,450 | $7.19 | $391.3K | 0 |
| Feb 25, 2021↗ | Kennedy Joseph T | General Counsel | Sell | 67,544 | $7.20 | $486.1K | 0 |
| Feb 25, 2021↗ | Ketchum Steven B | Chief Scientific Officer | Sell | 56,810 | $7.19 | $408.3K | 0 |
| Feb 25, 2021↗ | THERO JOHN F | President and CEO | Sell | 187,704 | $7.20 | $1.35M | 0 |
AMRN Insiders
Similar Stocks to AMRN
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B